November 04, 2025

Imaging Steatosis May Forecast Diabetes

MRI-based liver fat levels tracked insulin resistance and higher glucose readings.

Conexiant

November 04, 2025

FDA Approves First Drug for Thymidine Kinase 2 Deficiency

First-ever treatment shows significant survival benefit in matched-pair analysis of this ultra-rare mitochondrial depletion syndrome.

Conexiant

November 04, 2025

GLP-1s and Tirzepatide: Similar GI Risk

Real-world data show similar rates of severe GI events with semaglutide, dulaglutide, and tirzepatide, reinforcing comparable safety across agents in routine care.

Conexiant

November 04, 2025

Should SGLT-2 Inhibitors Be Continued After a UTI?

Patients with type 2 diabetes who developed urinary tract infections while taking sodium-glucose cotransporter-2 inhibitors faced higher heart and kidney risks.

Conexiant

November 03, 2025

Settlement Cash: Misused or Misread?

Opioid settlement funds were used for R&B concerts promoting addiction awareness in Irvington, New Jersey, highlighting broader debates over how opioid restitution money is spent nationwide.

KFF Health News

October 29, 2025

Can SGLT-2 Inhibitors Shield Against Autoimmune Disease?

Researchers found sodium-glucose cotransporter-2 inhibitors lowered autoimmune rheumatic disease risk by 11% in adults with type 2 diabetes.

Conexiant

October 29, 2025

Stable Rates Found in Childhood Type 2 Diabetes

5-year survey outlines social patterns in US pediatric patients with type 2 diabetes.

Conexiant

October 29, 2025

Could the Way You Walk Change Outcomes?

Researchers find that the duration of walking bouts—not just total daily steps—predicts long-term cardiovascular and mortality risk.

Conexiant

October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant